Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

New treatments for urological disorders claimed in recent Tanabe Seiyaku and Eisai patents

Dec. 21, 2005

New treatments for urinary incontinence claimed in recent patents

Dec. 13, 2005

Oral PDE5 inhibitor SLx-2101 begins phase IIa trial for erectile dysfunction

Dec. 2, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

Steroid 5alpha-reductase inhibitors for BPH from Schering AG

Nov. 29, 2005

Tolvaptan for autosomal dominant polycystic kidney disease

Nov. 17, 2005

Update on the long-term safety of lanthanum carbonate in dialysis patients

Nov. 15, 2005

SEW-2871: An S1P1 receptor agonist with renoprotective actions in vivo

Nov. 15, 2005

Renoprotective effects of pyridavone

Nov. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...